Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Duarte, California

Phase 1 cancer trials in Duarte, CA

109 Phase 1 cancer studies are recruiting participants at sites in Duarte as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Duarte at a glance

  • 109 studies are recruiting at a site in Duarte.
  • By phase: Early Phase 1 (2), Phase 1 (75), Phase 1/2 (32).
  • By sponsor: industry (71), university, hospital or other (32), government (6).
  • By research area: Lymphoma (53), Breast Cancer (22), Lung Cancer (20), Prostate Cancer (7), Pancreatic Cancer (5), Melanoma (2).
  • Most recent update to one of these records: November 17, 2026.

Breast cancer studies recruiting in Duarte

Basic details from each study's public record (the 30 most recently updated of 109). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Aktis Oncology, Inc.
    Study site
    City of Hope
    Registry record
    NCT07020117 · updated
  2. A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Stemline Therapeutics, Inc.
    Study site
    City of Hope
    Registry record
    NCT06638307 · updated
  3. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    City of Hope Comprehensive Cancer Center
    Registry record
    NCT07503808 · updated
  4. A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    City of Hope - Duarte
    Registry record
    NCT03424005 · updated
  5. Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    ORIC Pharmaceuticals
    Study site
    City of Hope
    Registry record
    NCT05315700 · updated
  6. A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    NiKang Therapeutics, Inc.
    Study site
    City of Hope
    Registry record
    NCT07029399 · updated
  7. A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study site
    City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
    Registry record
    NCT07318805 · updated
  8. A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    City of Hope National Medical Center
    Registry record
    NCT06465069 · updated
  9. A Study of LY4257496 in Participants With Cancer (OMNIRAY)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    City of Hope
    Registry record
    NCT07114601 · updated
  10. A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

    • Phase 1/2
    • Ages 18 and older
    • Female participants
    Sponsor
    Hoffmann-La Roche
    Study site
    City of Hope
    Registry record
    NCT04802759 · updated
  11. Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    City of Hope Medical Center
    Study site
    City of Hope Medical Center
    Registry record
    NCT06130826 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Duarte, CA on ClinicalTrials.gov.

Lung cancer studies recruiting in Duarte

  1. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    City of Hope Comprehensive Cancer Center
    Registry record
    NCT06287775 · updated
  2. A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    City of Hope Cancer Center-Duarte
    Registry record
    NCT07277413 · updated
  3. Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Study site
    City of Hope-Duarte-56419
    Registry record
    NCT04886804 · updated
  4. A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study site
    City of Hope National Medical Center
    Registry record
    NCT07090499 · updated
  5. First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Pierre Fabre Medicament
    Study site
    City of Hope
    Registry record
    NCT06043817 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Duarte, CA on ClinicalTrials.gov.

Prostate cancer studies recruiting in Duarte

  1. Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    Duarte Cancer Center
    Registry record
    NCT05997615 · updated
  2. Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Amgen
    Study site
    City of Hope National Medical Center
    Registry record
    NCT04221542 · updated
  3. PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    City of Hope Medical Center
    Study site
    City of Hope Medical Center
    Registry record
    NCT05805371 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Duarte, CA on ClinicalTrials.gov.

Lymphoma studies recruiting in Duarte

  1. Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

    • Phase 1/2
    • Ages 12 and older
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT07109219 · updated
  2. Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    City of Hope Medical Center
    Study site
    City of Hope Medical Center
    Registry record
    NCT07758673 · updated
  3. Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    City of Hope Comprehensive Cancer Center
    Registry record
    NCT05272384 · updated
  4. BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    PeproMene Bio, Inc.
    Study site
    City of Hope Medical Center
    Registry record
    NCT05370430 · updated
  5. Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    City of Hope Medical Center
    Study site
    City of Hope Medical Center
    Registry record
    NCT07278856 · updated
  6. Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    City of Hope Medical Center
    Study site
    City of Hope Medical Center
    Registry record
    NCT06922604 · updated
  7. A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    City of Hope
    Registry record
    NCT07101328 · updated
  8. A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    City of Hope
    Registry record
    NCT07226843 · updated
  9. Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    City of Hope Medical Center
    Study site
    City of Hope Medical Center
    Registry record
    NCT05371132 · updated
  10. 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

    • Phase 1
    • Ages 18 to 70
    • All sexes
    Sponsor
    City of Hope Medical Center
    Study site
    City of Hope Medical Center
    Registry record
    NCT06287944 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Duarte, CA on ClinicalTrials.gov.

Pancreatic cancer studies recruiting in Duarte

  1. Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    City of Hope Comprehensive Cancer Center
    Registry record
    NCT05372614 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Duarte, CA on ClinicalTrials.gov.

Ask about studies near Duarte

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in California

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call